Manufacturing

The Food and Drug Administration will review the investigational seasonal flu vaccine candidate after rejecting it earlier this month.

The president’s tariffs have created new economic opportunity for India, Brian Klein writes in a guest commentary.

Fourth-quarter earnings were $1.70 a share, down from $2.17 a year earlier.

The price of gold and silver reacted to ongoing talks between the U.S. and Iran.

Management forecast a decline in sales of farming equipment in 2026, while construction sales will be flat. Wall Street had expected growth in both areas.

Paramount Skydance stock rises after Warner Bros. Discovery says it will restart deal talks with the company.

Medtronic says it expects to take a $185 million hit from tariffs in the fiscal year.

Bonds and stocks have held up well despite recent political uncertainty. Investors should take a look.

Applied Materials shares surged after the semiconductor-equipment maker beat analysts’ quarterly earnings estimates.

U.S. steel and aluminum stocks were lower in early trading on Friday.

The explanation starts with the fact that many industries are undergoing changes, substantially altering their profit outlooks.  

Deutsche Bank scored its Buy-rated software stocks on “barriers to exit” for customers and “the ability to adapt to the gen-AI era.”

Exor owns stakes in a group of public and private companies, notably a nearly 20% stake in Ferrari, the top luxury car maker in the world. Its shares look cheap.

AppLovin and Cisco slide after reporting earnings while Fastly soars on better-than-expected quarterly profit and solid guidance.

Is any asset-light business model safe from artificial intelligence?

It’s not unusual for the battery maker’s shares to be volatile, and short interest in the stock has added to the uncertainty.

The machine-vision provider announced fourth-quarter earnings per share of 27 cents from sales of $252 million. Wall Street was looking for 22 cents and $239 million, respectively.

With investors suddenly jittery over software and other tech stocks, the script has flipped.

Robinhood reports weaker-than-expected growth in the fourth quarter while shares in Moderna tumble after the company says the Food and Drug Administration refuses to review a seasonal flu vaccine application.

Generac announced fourth-quarter earnings per share of $1.61 from sales of $1.1 billion. Wall Street was looking for $1.77 and $1.2 billion, respectively.

The Honeywell spinoff, is increasing production of uranium hexafluoride, an intermediate product between uranium ore and nuclear fuel pellets.

Solstice announces fourth-quarter Ebitda of $189 million from sales of $987 million. Wall Street was looking for Ebitda of $182 million from sales of $922 million.

Vertiv posts fourth-quarter earnings per share of $1.36 from sales of $2.9 billion. Wall Street was looking for $1.29 from sales of $2.9 billion.

The stock is roughly flat since our pick. We have reason to believe it will rally.

The company reported fourth-quarter earnings per share of 46 cents. Wall Street was looking for 43 cents.